Addressing high dose AAV toxicity - 'one and done' or 'slower and lower'?
EXPERT OPINION ON BIOLOGICAL THERAPY（2022）
Key words
Gene therapy, adeno-associated virus, AAV toxicity, hepatotoxicity, thrombotic microangiopathy, hepatocellular carcinoma, dorsal root ganglia toxicity, AAV capsid engineering, immune tolerance
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined